These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6977807)

  • 1. Decrease of alpha 1-antitrypsin during hemodialysis.
    Cristea A; Rus HG; Gherman M; Manasia M
    Med Interne; 1981; 19(4):379-81. PubMed ID: 6977807
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum trypsin inhibitory capacity in hemodialysis patients.
    Hashemi M; Mehrabifar H; Homayooni F; Naderi M; Montazerifar F; Ghavami S
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):604-7. PubMed ID: 19587500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency].
    Kotschy M; Kassian J; Lampka M; Rajewski W
    Pol Merkur Lekarski; 1997 Feb; 2(8):93-5. PubMed ID: 9538647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients].
    Wang HT; Peng YM; Liu H
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):266-8. PubMed ID: 14653086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Visceral pathology in the treatment of terminal kidney failure by programmed hemodialysis].
    Ardashev VN; Potekhin NP
    Voen Med Zh; 2000 Sep; 321(9):27-32. PubMed ID: 11077528
    [No Abstract]   [Full Text] [Related]  

  • 11. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical report on hemodialysis in the Department of Transplantation, Tokai University School of Medicine.
    Hida M; Saitoh H; Shiramizu T; Nakamura K; Shinbo T; Nakayama M; Satoh T
    Tokai J Exp Clin Med; 1981 Jul; 6(3):247-57. PubMed ID: 7303005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in platelet function in subjects with chronic renal insufficiency treated with periodical hemodialysis].
    Ferri GM; Taccone-Gallucci M; Bongiovanni P; Mazzarella V; Casciani CU
    Minerva Nefrol; 1981; 28(4):471-5. PubMed ID: 7339516
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W
    Ann Acad Med Stetin; 1981; 27():313-30. PubMed ID: 7345952
    [No Abstract]   [Full Text] [Related]  

  • 16. [Choice between renal transplantation and long-term hemodialysis].
    Crosnier J
    Bull Acad Natl Med; 1979; 163(6):553-8. PubMed ID: 15648320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heart rate variability alteration in patients on chronic hemodialysis].
    Salameh E; Mallat S; Hamdan R; Azar H; Azar R; Kadri Z; Kassab R; Abou Jaude S; Badaoui G
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):7-10. PubMed ID: 18980756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of hemodialysis in the treatment of end-stage kidney failure in GDR].
    Precht K; Lindenau R; Schultze EG; Dutz H; Klinkmann H
    Ter Arkh; 1982; 54(1):110-1. PubMed ID: 7079980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of arteriovenous shunts used in hemodialysis in chronic renal failure on various hemodynamic parameters].
    Dziewanowski K
    Kardiol Pol; 1981; 24(5):349-54. PubMed ID: 7265611
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of renal failure and hemodialysis on serum and urine myoglobin.
    Hart PM; Feinfeld DA; Briscoe AM; Nurse HM; Hotchkiss JL; Thomson GE
    Clin Nephrol; 1982 Sep; 18(3):141-3. PubMed ID: 7140026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.